IP Library Granted Patent US 9,988,357
Granted Patent B2
US 9,988,357 · App. 15/373,832 · Granted Jun 5, 2018

Methods for preparation of quinazoline derivatives

Inventors: Neelakandha S. Mani (San Diego, CA); Brett D. Allison (San Diego, CA); Zachary S. Sales (Escondido, CA); Jimmy T. Liang (San Diego, CA); Xiaohu Deng (San Diego, CA); Liansheng Li (San Diego, CA); Yun Oliver Long (San Diego, CA); Yuan Liu (San Diego, CA); Pingda Ren (San Diego, CA)
Assignee: Araxes Pharma LLC
C07D239/94C07D239/86
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,988,357
App. No.
15/373,832
Granted
Jun 5, 2018
Kind
B2
Abstract

Methods for preparing compounds having the following structure (I): or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein R 1 , R 2a , R 2b , R 3a , R 3b , R 4a , R 4b and R 4c , are as defined herein are provided. Related compounds and methods for making the same are also provided.

Claims (51)

1. A method for preparing a compound having the following structure (I):

or a pharmaceutically acceptable salt or stereoisomer thereof, wherein:

R 1 is a non-hydrogen substituent;

R 2a and R 2b are each independently halo, hydroxyl, protected hydroxyl, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl or C 1 -C 6 alkoxy;

R 3a and R 3b are each independently halo, hydroxyl, protected hydroxyl, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl or C 1 -C 6 alkoxy; or R 3a joins with R 4a to form a carbocyclyl or heterocyclyl ring, and R 3b is halo, hydroxyl, protected hydroxyl, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl or C 1 -C 6 alkoxy; and

R 4a , R 4b and R 4c are each independently H or a non-hydrogen substituent; or R 4a joins with R 3a to form a carbocyclyl or heterocyclyl ring, and R 4b and R 4c are each independently H or a non-hydrogen substituent;

wherein the method comprises preparing a mixture comprising a compound of structure (II) and a compound of structure (III), the compounds of structure (II) and (III) having the following structures, respectively:

or a salt thereof, wherein:

R 1′ is a non-hydrogen, non-acidic substituent;

R 2a′ and R 2b′ are each independently halo, protected hydroxyl, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl or C 1 -C 6 alkoxy;

R 3a′ and R 3b′ are each independently halo, protected hydroxyl, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl or C 1 -C 6 alkoxy; or R 3a′ joins with R 4a′ to form a carbocyclyl or heterocyclyl ring, and R 3b′ is halo, protected hydroxyl, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl or C 1 -C 6 alkoxy;

R 4a′ , R 4b′ and R 4c′ are each independently H or a non-hydrogen substituent; or R 4a′ joins with R 3a′ to form a carbocyclyl or heterocyclyl ring, and R 4b′ and R 4c′ are each independently H or a non-hydrogen substituent; and

X is a leaving group,

thereby forming a carbon-carbon bond between the carbon bearing the Zn moiety on compound (II) and the carbon bearing the X moiety on compound (III).

2. The method of claim 1 , wherein the compound of structure (II) is prepared by reaction of a mixed-metal, heterocyclyl base with a compound having the following structure (IV):

3. The method of claim 2 , wherein the mixed metal, heterocyclyl base comprises Zn, Mg and Li.

4. The method of claim 2 , wherein the mixed metal, heterocyclyl base comprises a piperidinyl heterocycle.

5. The method of claim 2 , wherein the mixed metal, heterocyclyl base comprises a 2,2,6,6-Bis(tetramethylpiperidine)zinc, magnesium chloride, lithium chloride complex ((tmp) 2 Zn.2MgCl 2 .2LiCl).

6. The method of claim 1 , wherein the mixture comprising a compound of structure (II) and a compound of structure (III) further comprises a metal catalyst or metal precatalyst.

7. The method of claim 6 , wherein the metal is palladium.

8. The method of claim 7 , wherein the metal precatalyst is CPhos 3 rd generation.

9. The method of claim 1 , wherein the mixture comprising a compound of structure (II) and a compound of structure (III) comprises a polar, aprotic solvent.

10. The method of claim 9 , wherein the solvent is tetrahydrofuran.

11. The method of claim 1 , wherein R 1 and R 1′ are each independently C 1 -C 6 alkyl, carbocyclyl or heterocyclyl.

12. The method of claim 11 , wherein R 1 and R 1′ are each independently heterocyclyl.

13. The method of claim 12 , wherein heterocyclyl is piperazinyl.

14. The method of claim 1 , wherein R 1 and R 1′ each have the following structure:

wherein P is a nitrogen protecting group.

15. The method of claim 14 , wherein P is butyloxycarbonyl (Boc).

16. The method of claim 1 , wherein R 2a and R 2b are each independently halo.

17. The method of claim 1 , wherein R 2a′ and R 2b′ are each independently halo.

18. The method of claim 1 , wherein R 3a and R 3b are each independently halo, hydroxyl or C 1 -C 6 alkoxy.

19. The method of claim 1 , wherein R 3a′ and R 3b′ are each independently halo or C 1 -C 6 alkoxy.

20. The method of claim 1 , wherein R 4a , R 4b and R 4c are each independently H.

21. The method of claim 1 , wherein R 4a′ , R 4b′ and R 4c′ are each independently H.

22. The method of claim 1 , wherein X is halo.

23. The method of claim 22 , wherein halo is bromo.

24. The method of claim 1 , wherein the compound of structure (II) has one of the following structures:

25. The method of claim 1 , wherein the compound of structure (III) has one of the following structures:

wherein P 1 is nitrogen protecting group.

26. The method of claim 1 , comprising the following steps (a) and (b):

wherein:

R 2a , R 2b , R 2a′ and R 2b′ are each independently halo;

R 3a , R 3b , R 3a′ and R 3b′ are each independently halo, protected hydroxyl or C 1 -C 6 alkoxy; and

R 4a , R 4b , R 4c , R 4a′ , R 4b′ and R 4c′ are each independently H.

27. The method of claim 26 , wherein P is butyloxycarbonyl.

28. The method of claim 26 , wherein R 2a , R 2b , R 2a′ and R 2b′ are each independently chloro or fluoro.

29. The method of claim 26 , wherein R 2a and R 2b′ are each chloro, and R 2b and R 2b′ are each fluoro.

30. The method of claim 26 , wherein R 3a , R 3b R 3a′ and R 3b′ are each independently halo or C 1 -C 6 alkoxy.

31. The method of claim 30 , wherein halo is fluoro and C 1 -C 6 alkoxy is methoxy.

32. The method of claim 31 , wherein R 3a and R 3a′ are each fluoro, and R 3b and R 3b′ are each methoxy.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2021
From: JANSSEN BIOTECH, INC.
To: ARAXES PHARMA LLC
Reel/Frame 058604/0004 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2021
From: ARAXES PHARMA LLC
To: ARAXES PHARMA LLC; JANSSEN BIOTECH, INC.
Reel/Frame 056969/0864 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2018
From: MANI, NEELAKANDHA S.; ALLISON, BRETT D.; SALES, ZACHARY S.; LIANG, JIMMY T.
To: JANSSEN BIOTECH, INC.
Reel/Frame 045451/0982 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2018
From: JANSSEN BIOTECH, INC.
To: ARAXES PHARMA LLC
Reel/Frame 045452/0039 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2018
From: DENG, XIAOHU; LI, LIANSHENG; LONG, YUN OLIVER; LIU, YUAN; REN, PINGDA
To: ARAXES PHARMA LLC
Reel/Frame 045051/0504 →
Continuity (2)
Provisional Application 62265303 · Dec 9, 2015
Related Publication 20170190672A1 · Jul 6, 2017